Profile picture for Akhil Sood, MD

Akhil Sood, MD

Akhil Sood is a Rheumatology & Immunology fellow at Stanford University and a Master’s candidate in Epidemiology & Clinical Research. His work focuses on understanding barriers and facilitators to guideline adherence in reproductive health in patients with systemic lupus erythematosus (SLE), with interests in epidemiology, health equity, and quality improvement. Follow him on Twitter @AkhilSoodMD.

 

 

Articles By Akhil Sood, MD

Back Pain

Thinking Outside the Box: Novel Strategies for Early Detection of AxSpA

By Akhil Sood, MD

Strategies to identify patients with suspected inflammatory back pain in the general population is critical for timely and proper diagnosis.

Read Article
covid coronavirus virus

Long COVID and Rheumatic Disease

By Akhil Sood, MD

The COVID-19 pandemic has had a significant impact worldwide particularly among those who are immunocompromised. Numerous studies have highlighted the increased risk of acute SARS-CoV-2 infection among patients with rheumatic diseases (RD).

Read Article
brain.mri2_.jpg

Cognitive Impairment in Patients with Rheumatoid Arthritis

By Akhil Sood, MD

Evidence suggests that RA patients are at increased risk for cognitive impairment. This is likely mediated by certain factors, including chronic inflammation and accelerated atherosclerosis. In the clinical setting, it is important to identify RA patients at increased risk for cognitive impairment.

Read Article
covid coronavirus virus

Outcomes of COVID-19 in Patients with Rheumatoid Arthritis

By Akhil Sood, MD

Patients with rheumatic diseases – requiring lifelong immunosuppressants— are at high risk for respiratory and viral infections. Over the past decade, an armamentarium of biologic and targeted therapies has led to better control of disease activity in patients with rheumatoid arthritis. Whether these patients, especially those receiving newer biological and targeted therapies such as JAK inhibitors, are at an increased risk of severe COVID-19 outcomes remains uncertain. 

Read Article
×